Does the Triglyceride-glucose (TyG) index predict the risk of subclinical heart failure with preserved ejection fraction in patients with type 2 diabetes?
The TyG index may serve as a novel marker to predict the risk of subclinical HFpEF in patients with type 2 diabetes.
The TyG index showed a positive correlation with the risk of subclinical HFpEF in patients with T2DM, providing a new marker to predict and treat HFpEF in diabetes.
Wang et al. (Mon,) studied this question.